181 related articles for article (PubMed ID: 2143474)
21. A comparison of SepPak and high-performance liquid chromatography as techniques for measuring the radiochemical purity of 99mTc-MAG3.
Millar AM; Hesslewood SR
Nucl Med Commun; 2004 Oct; 25(10):1049-51. PubMed ID: 15381873
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of technetium-99m-L,L-EC in renal transplant recipients: a comparative study with technetium-99m-MAG3 and iodine-125-OIH.
Stoffel M; Jamar F; Van Nerom C; Verbruggen A; Mourad M; Leners N; Squifflet JP; Beckers C
J Nucl Med; 1994 Dec; 35(12):1951-8. PubMed ID: 7989976
[TBL] [Abstract][Full Text] [Related]
23. Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine.
Taylor A; Ziffer JA; Steves A; Eshima D; Delaney VB; Welchel JD
Radiology; 1989 Mar; 170(3 Pt 1):721-5. PubMed ID: 2521734
[TBL] [Abstract][Full Text] [Related]
24. Estimation of technetium-99m-MAG3 plasma clearance in adults from one or two blood samples.
Russell CD; Taylor A; Eshima D
J Nucl Med; 1989 Dec; 30(12):1955-9. PubMed ID: 2531219
[TBL] [Abstract][Full Text] [Related]
25. Radiochemical purity of 99mTc-HM-PAO: critical parameters during kit preparation.
Seifert S; Muth O; Jantsch K; Johannsen B
Nucl Med Biol; 1995 Nov; 22(8):1063-6. PubMed ID: 8998468
[No Abstract] [Full Text] [Related]
26. Validation of alternative methods of preparing 99mTc-MAG3.
Seetharaman S; Sosabowski MH; Ballinger JR
Appl Radiat Isot; 2007 Nov; 65(11):1240-3. PubMed ID: 17434313
[TBL] [Abstract][Full Text] [Related]
27. A study of the concept of non-radioactive unit-dosed reagent kits [cold unit doses (CUDs)] as an efficient and cost-saving method for 99mTc radiopharmaceutical preparation.
Lerthirunwong C; Cheng KT; Hladik WB
Int J Rad Appl Instrum B; 1992 Oct; 19(7):727-35. PubMed ID: 1399692
[TBL] [Abstract][Full Text] [Related]
28. Testing different storage conditions for (99m)Tc-MAG3 kit: can hot fractioning reduce the cost per unit dose?
Kiratli PO; Salanci BV
J Nucl Med Technol; 2003 Jun; 31(2):74-5. PubMed ID: 12777456
[TBL] [Abstract][Full Text] [Related]
29. A method for stabilising technetium-99m exametazime prepared from a commercial kit.
Weisner PS; Bower GR; Dollimore LA; Forster AM; Higley B; Storey AE
Eur J Nucl Med; 1993 Aug; 20(8):661-6. PubMed ID: 8404951
[TBL] [Abstract][Full Text] [Related]
30. [A comparative evaluation of iodine-131 OIH and technetium-99m MAG3 in the study of renal function].
Di Lorenzo I; Stiglich F; Barbonetti C; Bonomo F; Maspero S; Paini S; Bottinelli G
Radiol Med; 1990 Apr; 79(4):376-80. PubMed ID: 2143030
[TBL] [Abstract][Full Text] [Related]
31. Effects of alternative reconstitution procedures on the labelling efficiency and in vitro stability of 99Tcm-labelled radiopharmaceuticals.
Bogsrud TV; Chen MN; Herold TJ; Mahoney DW; Hung JC
Nucl Med Commun; 1999 Jan; 20(1):61-5. PubMed ID: 9949414
[TBL] [Abstract][Full Text] [Related]
32. Transferability of a two-strip method for the quality control of technetium-99m mercaptoacetyltriglycine ([
Tessaire T; De Neef L; Cailly T; Peyronnet D; Vigne J
Eur J Hosp Pharm; 2023 May; 30(3):167-171. PubMed ID: 34285112
[TBL] [Abstract][Full Text] [Related]
33. Effect of pertechnetate source and age on the radiochemical purity of technetium Tc 99m exametazime.
Ponto JA
Am J Hosp Pharm; 1990 Nov; 47(11):2511-3. PubMed ID: 2177584
[TBL] [Abstract][Full Text] [Related]
34. Generator eluate effects on the labeling efficiency of 99mTc-sestamibi.
Hung JC; Herold TJ; Wilson ME; Gibbons RJ
Nucl Med Biol; 1995 Oct; 22(7):949-51. PubMed ID: 8547894
[TBL] [Abstract][Full Text] [Related]
35. Technetium-99m-MAG3 versus iodine-123-OIH: renal clearance and distribution volume as measured by a constant infusion technique.
Prenen JA; de Klerk JM; van het Schip AD; van Rijk PP
J Nucl Med; 1991 Nov; 32(11):2057-60. PubMed ID: 1834812
[TBL] [Abstract][Full Text] [Related]
36. Investigation of the labelling characteristics of 99mTc-mercaptoacetyltriglycine.
Bormans G; Cleynhens B; Adriaens P; Vanbilloen H; De Roo M; Verbruggen A
Nucl Med Biol; 1995 Apr; 22(3):339-49. PubMed ID: 7627149
[TBL] [Abstract][Full Text] [Related]
37. Effect of the NSAID diclofenac on 99mTc-MAG3 and 99mTc-DTPA renography.
Mustafa S; Elgazzar AH
J Nucl Med; 2013 May; 54(5):801-6. PubMed ID: 23528384
[TBL] [Abstract][Full Text] [Related]
38. The influence of generator eluate on the radiochemical purity of 99Tcm-sestamibi prepared using fractionated Cardiolite kits.
Varelis P; Parkes SL; Poot MT
Nucl Med Commun; 1998 Jul; 19(7):615-23. PubMed ID: 9853341
[TBL] [Abstract][Full Text] [Related]
39. [99mTc-MAG3 and 131I-OIH in patients with kidney insufficiency and with normal kidneys].
Keske U; Cordes M; Wilfling M; Hunger J; Hosten N; Gahl G
Rofo; 1990 Mar; 152(3):287-92. PubMed ID: 2157251
[TBL] [Abstract][Full Text] [Related]
40. Stabilisation of high-activity 99mTc-d,l-HMPAO preparations with cobalt chloride and their biological behaviour.
Mang'era KO; Vanbilloen HP; Schiepers CW; Verbruggen AM
Eur J Nucl Med; 1995 Oct; 22(10):1163-72. PubMed ID: 8542901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
